SCHEMBL6188217

SCHEMBL6188217

CCCNC(=O)C1(CCCCN2CCC(N3C(=O)c4ccccc4C3=O)CC2)c2ccccc2-c2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MTTP P55157 3/20 0.48
KCNH2 Q12809 2/20 0.48
CHRM2 P08172 1/20 0.48
ADRA2A P08913 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
CHRM1 P11229 1/20 0.48
DRD1 P21728 1/20 0.48
TBXA2R P21731 1/20 0.48
PTGS1 P23219 1/20 0.48
SLC6A2 P23975 1/20 0.48
ADRA1A P35348 1/20 0.48
OPRM1 P35372 1/20 0.48
DRD3 P35462 1/20 0.48
SLC6A3 Q01959 1/20 0.48
MTR Q99707 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.46
DRD2 P14416 1/20 0.43
SLC6A4 P31645 1/20 0.43
CHRM3 P20309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6190218 0.89 MTTP (0.42) MTTPKCNH2CHRM2ADRA2AADORA3
SCHEMBL4208514 0.87 MTR (0.48) MTTPKCNH2CHRM2ADRA2AADORA3
SCHEMBL6192487 0.86 MTTP (0.47) MTTPKCNH2CHRM2ADRA2AADORA3
SCHEMBL6607670 0.86 MTR (0.47) MTTPKCNH2CHRM2ADRA2AADORA3
SCHEMBL6190006 0.86 MTTP (0.57) MTTPKCNH2CHRM2ADRA2AADORA3
SCHEMBL6187741 0.84 MTR (0.48) MTTPKCNH2CHRM2ADRA2AADORA3
SCHEMBL8904893 0.83 MTTP (0.45) MTTPKCNH2CHRM2ADRA2AADORA3
SCHEMBL6186372 0.82 MTTP (0.59) MTTPKCNH2CHRM2ADRA2AADORA3
SCHEMBL8896731 0.80 MTTP (0.51) MTTPKCNH2CHRM2ADRA2AADORA3
SCHEMBL6600299 0.80 MTR (0.50) MTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6034098-A ATHEROSCLEROSIS BRISTOL-MYERS SQUIBB COMPANY (US) 2000-03-07 US claimed
WO-1996026205-A1 INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 1996-08-29 WO claimed
EP-0886637-B9 INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD BRISTOL MYERS SQUIBB CO (US) 2005-05-04 EP disclosed
EP-0886637-B1 INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD BRISTOL MYERS SQUIBB CO (US) 2004-12-01 EP disclosed
US-6066650-A USEFUL FOR LOWERING SERUM LIPIDS AND TREATING ATHEROSCLEROSIS AND RELATED DISEASES BRISTOL-MYERS SQUIBB COMPANY (US) 2000-05-23 US disclosed
US-6034098-A ATHEROSCLEROSIS BRISTOL-MYERS SQUIBB COMPANY (US) 2000-03-07 US disclosed